Clinical Trials Logo

Clinical Trial Summary

This is a multicenter, randomized, double-blind, single-dose, placebo-controlled, 2-period, crossover study to evaluate the efficacy and safety of budesonide/albuterol metered-dose inhaler (BDA MDI/PT027) as compared with a placebo metered-dose inhaler (placebo MDI) on exercise-induced bronchoconstriction (EIB) in adult and adolescent subjects with asthma. Subjects will receive each study treatment on separate visits and undergo a treadmill exercise challenge test for up to 10 minutes so that the effect of study treatment on exercise-induced bronchoconstriction can be evaluated.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04234464
Study type Interventional
Source Bond Avillion 2 Development LP
Contact
Status Completed
Phase Phase 3
Start date January 15, 2020
Completion date August 28, 2020

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05162703 - Evaluation of Exercise Induced Bronchoconstriction Using a Novel Automated Digital Clinical Decision System N/A
Terminated NCT03586544 - Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity Phase 4
Recruiting NCT03505216 - Swiss Paediatric Airway Cohort
Recruiting NCT03063424 - Hyperventilation Versus Exercise Testing Sensitivity in Exercise Induced Asthma N/A
Active, not recruiting NCT03587675 - Diagnosis of EIB in Young Elite Athletes (13-18 y) N/A
Recruiting NCT05105529 - Adaptation to Ozone in Individuals With Asthma/Exercise-induced Bronchoconstriction N/A
Recruiting NCT06336681 - Inspiratory Muscle Training on The Severity of Exercise-Induced Bronchoconstriction and Time-Trial Performance (IMT_EIB) Phase 2
Completed NCT00273689 - Exercise Induced Bronchospasm in Children Phase 4